Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 10Unknown 9Recruiting 4Terminated 3Active not recruiting 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Ovarian Neoplasms 3Stomach Neoplasms 2Carcinoma, Ovarian Epithelial 2Peritoneal Neoplasms 1Ovarian Epithelial Cancer Recurrent 1Neoplasm Metastasis 1HIPEC 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Appendiceal Neoplasms 1

Interventions

pembrolizumab 24Carboplatin 21Paclitaxel 20olaparib 19Magnetic Resonance Spectroscopy 14Bevacizumab 14Cyclophosphamide 12Specimen Handling 11Nivolumab 11Gemcitabine 11Taxes 10niraparib 8Cisplatin 8Biopsy 8liposomal doxorubicin 7fludarabine 7Surveys and Questionnaires 6Immunoglobulin G 6Doxorubicin 6Disulfides 6durvalumab 5palbociclib 4oregovomab 4X-Rays 4Ipilimumab 4mirvetuximab soravtansine 3ipatasertib 3defactinib 3cediranib 3atezolizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Ovarian Neoplasms × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT03842982 2026-03-16

CHIPPI

Centre Oscar Lambret

Phase 3 Active not recruiting
362 enrolled
Gynecologic

Ovarian Neoplasms

NCT05316181 2026-02-12

KOV-HIPEC-02R

National Cancer Center, Korea

Phase 3 Active not recruiting
140 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT02124421 2024-11-19

CRS/HIPEC

Mercy Medical Center

Phase 2 Active not recruiting
32 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡